small molecule

BUPHENYL

SODIUM PHENYLBUTYRATE

Loss of exclusivity—loss of exclusivity
CompanyHORIZON THERAPEUTICS US HOLDING LLC

Drug detail

Brand nameBUPHENYL
Active ingredientSODIUM PHENYLBUTYRATE
Strength500MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalMay 1996
Marketing statusDISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.